PLALAB PLACENTA MASK- niacinamide, adenosine patch
RENOCELL Co., Ltd

Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

----------

Plalab Placenta Mask

Niacinamide (2%)
Adenosine (0.04%)

Skin Protectant

Keep out of reach of children
 Do not swallow. In case of accidental ingestion, seek professional assistance.

Moisturizes skin. Keep skin soft and smooth and helps to improve skin elasticity. Whitening and wrinkle care.

Warnings
For external use only
Do not use when Your skin is red, inflamed, irritated or painful
When using this product
 Do not apply on other parts of the body
 Avoid contact with eyes. If contact occurs, rinse eyes thoroughly with water.
 Do not apply directly to wound or open cut.
Stop use and ask doctor if rash or irritation on skin develops and lasts.
Store at room temperature

Directions
After cleansing and toning the face, put mask onto face carefully for 20 minutes to absorb completely. Remove mask and gently pat remaining onto skin and follow with Plalab Placenta Cream R-20.

Water, Glycerin, Butylene Glycol, 1,2-Hexanediol, Betaine, Horse Fat, Pentaerythrityl Tetraethylhexanoate, Lactobacillus/Soybean Ferment Extract, Saccharomyces/Viscum Album (Mistletoe) Ferment Extract, Saccharomyces/Imperata Cylindrica Root Ferment Extract, Polyacrylate-13, Polyisobutene, Polysorbate 20, Placental Protein, Trehalose, Sodium Hyaluronate, Swiftlet Nest Extract, Dimethicone, Zanthoxylum Piperitum Fruit Extract, Pulsatilla Koreana Extract, Usnea Barbata (Lichen) Extract, Fragrance

Plalab Placenta Mask

mask pack

PLALAB PLACENTA MASK
niacinamide, adenosine patch

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC:70326-104
Route of Administration	TOPICAL

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
NIACINAMIDE (UNII: 25X51I8RD4) (NIACINAMIDE - UNII:25X51I8RD4)	NIACINAMIDE	0.02 in 25 mL
ADENOSINE (UNII: K72T3FS567) (ADENOSINE - UNII:K72T3FS567)	ADENOSINE	0.0004 in 25 mL

Ingredient Name	Strength
Inactive Ingredients
water (UNII: 059QF0KO0R)
GLYCERIN (UNII: PDC6A3C0OX)
Butylene Glycol (UNII: 3XUS85K0RA)
1,2-Hexanediol (UNII: TR046Y3K1G)
Betaine (UNII: 3SCV180C9W)
Pentaerythrityl Tetraethylhexanoate (UNII: XJ7052W897)
POLYISOBUTYLENE (1000 MW) (UNII: 5XB3A63Y52)
Polysorbate 20 (UNII: 7T1F30V5YH)
SUS SCROFA PLACENTA (UNII: C8CV8867O8)
Trehalose (UNII: B8WCK70T7I)
HYALURONATE SODIUM (UNII: YSE9PPT4TH)
Dimethicone (UNII: 92RU3N3Y1O)
ZANTHOXYLUM PIPERITUM FRUIT PULP (UNII: 7PFC2VA251)
PULSATILLA KOREANA ROOT (UNII: FY35I16MPL)
USNEA BARBATA (UNII: D6DVA9TCAP)

#	Item Code	Package Description	Marketing Start Date	Marketing End Date
Packaging
1	NDC:70326-104-02	1 in 1 PACKAGE
1	NDC:70326-104-01	25 mL in 1 PATCH; Type 0: Not a Combination Product

Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
Marketing Information
unapproved drug other		12/23/2015

Labeler - RENOCELL Co., Ltd (689605795)

Registrant - RENOCELL Co., Ltd (689605795)

Name	Address	ID/FEI	Business Operations
Establishment
RENOCELL Co., Ltd		689605795	manufacture(70326-104)

Revised: 12/2015

Document Id: a578a8cf-b315-4cb2-8b98-cf88487fb7dc

Set id: 25f49daa-8567-4cdb-9194-b1a31cf87bad

Version: 2

Effective Time: 20151223

RENOCELL Co., Ltd